DRD3 Gene

📖 Wiki Page

gene989 wordssynced 2026-04-02

DRD3 Gene — Dopamine Receptor D3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DRD3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>DRD3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dopamine Receptor D3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3q13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1818</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000151577</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P35462</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>139251</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>G Protein-Coupled Receptor (Class A)</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Human</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), Restless Leg Syndrome, Schizophrenia, Dyskinesias, Addiction</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Pramipexole</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">Ropinirole</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">Rotigotine</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">Cariprazine</td>
<td>Partial agonist</td>
</tr>
</table>

Introduction

...

DRD3 Gene — Dopamine Receptor D3

Introduction

Drd3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

The DRD3 gene encodes the dopamine D3 receptor (D3R), a Gi/o protein-coupled receptor that is predominantly expressed in the limbic system and plays critical roles in reward, motivation, and movement control. D3R is a major therapeutic target for Parkinson's disease, particularly in the context of levodopa-induced dyskinesias, and is implicated in addiction, schizophrenia, and restless leg syndrome. The D3 receptor exhibits approximately 10-fold higher affinity for dopamine compared to the D2 receptor, making it particularly sensitive to endogenous dopamine fluctuations.

Molecular Function

The D3 receptor is a member of the D2-like dopamine receptor family (along with DRD2 and DRD4) and couples primarily to Gi/o proteins, leading to:

Inhibition of adenylyl cyclase: Reduces cAMP production, counteracting D1-like receptor effects
Activation of G protein-gated potassium channels (GIRK): Causes hyperpolarization, reducing neuronal firing
Inhibition of voltage-gated calcium channels: Reduces neurotransmitter release
Modulation of MAPK/ERK signaling: Affects gene expression and neuronal plasticity
β-arrestin recruitment: Triggers downstream signaling cascades

Key characteristics:

Highest dopamine affinity among dopamine receptors (Kd ~ 0.9 nM)
Preferential localization to limbic system regions
Exists in both pre- and postsynaptic locations as autoreceptors and postsynaptic receptors
Alternative splicing produces multiple receptor isoforms

Expression Pattern

Brain Distribution

Highest expression: Nucleus accumbens (shell > core), islands of Calleja, olfactory tubercle
High expression: Striatum (patch compartment), ventral pallidum
Moderate expression: Substantia nigra (pars compacta), ventral tegmental area, [hippocampus](/brain-regions/hippocampus), amygdala
Low expression: Cerebral [cortex](/brain-regions/cortex), cerebellum

Peripheral Expression

Kidney: High expression in renal tubules
Immune cells: Lymphocytes, monocytes express DRD3
Cardiovascular: Low expression in heart and blood vessels
Endocrine: Pituitary gland expression

Role in Neurodegenerative Diseases

Parkinson's Disease

D3R plays a complex and central role in PD pathophysiology and treatment:

Altered expression: Postmortem studies show increased D3R binding in the striatum of PD patients, particularly in early disease stages
Levodopa-induced dyskinesias (LID): D3R is heavily implicated in the development of LID; D3R-deficient mice show reduced dyskinesias
Therapeutic targeting: D3R-selective agonists (e.g., pramipexole, ropinirole) are first-line PD treatments that may have disease-modifying potential
Genetic variants: DRD3 polymorphisms (Ser9Gly) affect PD risk, age of onset, and treatment response
D3R vs D2R selectivity: Agonists with higher D3:D2 selectivity may reduce dyskinesia risk

Restless Leg Syndrome (RLS)

First-line treatments: D3R agonists (pramipexole, ropinirole, rotigotine) are FDA-approved for RLS
Pathophysiology: D3R dysfunction in the mesolimbic pathway contributes to RLS sensory-motor symptoms
Augmentation risk: Long-term use may lead to augmentation (worsening symptoms)

Schizophrenia

Negative symptoms: D3R antagonists may improve negative symptoms and cognitive deficits
Antipsychotic binding: Most antipsychotics have high D3R occupancy (e.g., clozapine, cariprazine)
Gene associations: DRD3 polymorphisms linked to schizophrenia susceptibility

Addiction

Reward pathway: D3R in nucleus accumbens mediates reward conditioning
Drug seeking: D3R antagonists reduce cocaine, alcohol, and nicotine seeking in preclinical models
Individual vulnerability: DRD3 variants influence addiction risk

Therapeutic Implications

Current Therapeutics

Research Directions

D3R-selective agonists: Develop compounds with higher D3:D2 ratio to reduce dyskinesias
Allosteric modulators: Target allosteric sites for more selective modulation
β-arrestin biased agonists: Bias toward β-arrestin pathways may provide benefits
Gene therapy: Viral vector delivery of D3R genes under investigation

Animal Models

DRD3 Knockout Mice

Enhanced baseline locomotor activity
Reduced cocaine self-administration and reinforcement
Altered reward processing and emotional behavior
Improved working memory performance
Reduced levodopa-induced dyskinesias

Transgenic Models

D3R overexpression leads to enhanced rewarding effects of cocaine
Humanized DRD3 mice for drug testing
PD models with D3R manipulation show altered dyskinesia phenotypes

Research Directions

Biomarkers: D3R imaging ligands for PD progression

Personalized medicine: DRD3 genotyping for treatment selection

Disease modification: D3R agonists as disease-modifying agents

Combination therapies: D3R-targeted approaches with other mechanisms

Background

The study of Drd3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene: DRD3](https://www.ncbi.nlm.nih.gov/gene/1818)
[UniProt: DRD3](https://www.uniprot.org/uniprot/P35462)
[Human Protein Atlas: DRD3](https://www.proteinatlas.org/ENSG00000151577-DRD3)
[IUPHAR Database: D3 Receptor](https://www.guidetopharmacology.org/GRID/IUPHAR/D3.jsp)

References

[Unknown, - Human dopamine D3 receptor gene: structure and expression (n.d.)](PMID: 2154083(https://pubmed.ncbi.nlm.nih.gov/2154083/))

[Unknown, - D3 receptor in the limbic system: localization and function (n.d.)](PMID: 8288280(https://pubmed.ncbi.nlm.nih.gov/8288280/))

[Unknown, - Dopamine D3 receptor and Parkinson's disease (n.d.)](PMID: 10619475(https://pubmed.ncbi.nlm.nih.gov/10619475/))

[Unknown, - Role of D3 receptors in levodopa-induced dyskinesias (n.d.)](PMID: 14598257(https://pubmed.ncbi.nlm.nih.gov/14598257/))

[Unknown, - Therapeutic targeting of dopamine D3 receptor (n.d.)](PMID: 15723239(https://pubmed.ncbi.nlm.nih.gov/15723239/))

[Unknown, - D3 receptor mechanisms in addiction (n.d.)](PMID: 19126755(https://pubmed.ncbi.nlm.nih.gov/19126755/))

[Unknown, - Restless leg syndrome and dopamine receptors (n.d.)](PMID: 23651826(https://pubmed.ncbi.nlm.nih.gov/23651826/))

[Unknown, - DRD3 polymorphisms in Parkinson's disease (n.d.)](PMID: 26786091(https://pubmed.ncbi.nlm.nih.gov/26786091/))

Pathway Diagram

The following diagram shows the key molecular relationships involving DRD3 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

DRD3 Gene

DRD3 Gene — Dopamine Receptor D3

Introduction

DRD3 Gene — Dopamine Receptor D3

Introduction

Overview

Molecular Function

Expression Pattern

Brain Distribution

Peripheral Expression

Role in Neurodegenerative Diseases

Parkinson's Disease

Restless Leg Syndrome (RLS)

Schizophrenia

Addiction

Therapeutic Implications

Current Therapeutics

Research Directions

Animal Models

DRD3 Knockout Mice

Transgenic Models

Research Directions

Background

See Also

External Links

References

Pathway Diagram